Stool DNA testing to screen for colorectal cancer in the medicare population: A cost-effectiveness analysis

Medicine and Dentistry

• Adenoma 8%
• Analysis 8%
• Base 8%
• Carcinoma 8%
• Colorectal Cancer 100%
• Colorectal Cancer Screening 41%
• Cost-Effectiveness Analysis 100%
• DNA 100%
• Health Care Cost 100%
• Healthcare Research 8%
• Life Expectancy 8%
• Lifespan 16%
• Medicare 100%
• Quality of Care 8%
• Screening 16%
• Screening Test 16%
• Sensitivity Analysis 16%
• Sensitivity and Specificity 8%

Nursing and Health Professions

• Adenoma 9%
• Analysis 9%
• Base 9%
• Cancer Screening 45%
• Carcinoma 9%
• Colorectal Cancer 100%
• Cost Effectiveness Analysis 100%
• DNA 100%
• Incremental Cost-Effectiveness Ratio 9%
• Life Expectancy 9%
• Medicaid 18%
• Medicare 100%
• Person 36%
• Screening 18%
• Screening Test 18%
• Sensitivity Analysis 18%
• Sensitivity and Specificity 9%
• Time 9%